Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression.

Wei ZhengYan-Ling ZhouCheng-Yu WangXiao-Feng LanBin ZhangSu-Miao ZhouSu YanMing-Zhe YangSha NieYu-Ping Ning

Published in: Therapeutic advances in psychopharmacology (2021)

This study indicated that VEGF may not be a potential predictor of antidepressant response to repeated intravenous administration of ketamine in patients with depression.

Keyphrases

major depressive disorder
vascular endothelial growth factor
depressive symptoms
endothelial cells
pain management
sleep quality
high dose
risk assessment
climate change
physical activity
chronic pain